Resmed (RSMDF) Interest & Investment Income (2009 - 2026)
Resmed's (RSMDF) quarterly Interest & Investment Income came in at $20.9 million in Q2 2026, up 262.78% on a YoY basis from $5.8 million in Q2 2025, and up 69.98% quarter-over-quarter from $12.3 million in Q1 2026.
Powered by 
Analysis
Resmed (RSMDF) Interest & Investment Income (2009 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Interest & Investment Income for 17 consecutive years, with $20.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income rose 262.78% year-over-year to $20.9 million; the trailing twelve-month figure through Jun 2026 stood at $49.9 million (up 1113.27% YoY), and the FY2026 full-year result was $49.9 million, up 1113.27% from the prior year.
- Interest & Investment Income grew to $20.9 million in Q2 2026 per RSMDF's latest filing, from $12.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $20.9 million in Q2 2026 and bottomed at -$15.0 million in Q3 2023.
- Historically, Interest & Investment Income has averaged $693250.0 across 4 years, with a median of $9000.0 in 2024.
- The sharpest annual moves came in 2024 and 2026: Interest & Investment Income jumped 88.89% in 2024, then jumped 1449.43% in 2026.
- Over 4 years, Interest & Investment Income stood at -$13.8 million in 2023, then soared by 94.39% to -$775000.0 in 2024, then soared by 1125.68% to $7.9 million in 2025, then soared by 162.74% to $20.9 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $20.9 million, $12.3 million, and $7.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | - |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 20.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.89 Mn |
| Mar 31, 2026 | 12.29 Mn |
| Dec 31, 2025 | 7.95 Mn |
| Sep 30, 2025 | 8.79 Mn |
| Jun 30, 2025 | 5.76 Mn |
| Mar 31, 2025 | 793,000.00 |
| Dec 31, 2024 | -775,000.00 |
| Sep 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | -5.92 Mn |
| Mar 31, 2024 | -11.03 Mn |
| Dec 31, 2023 | -13.81 Mn |
| Sep 30, 2023 | -14.96 Mn |
| Jun 30, 2021 | 59,000.00 |
| Mar 31, 2021 | 55,000.00 |
| Dec 31, 2020 | 132,000.00 |
| Sep 30, 2020 | 117,000.00 |
| Jun 30, 2020 | 255,000.00 |
| Mar 31, 2020 | 116,000.00 |
| Dec 31, 2019 | 202,000.00 |
| Sep 30, 2019 | 449,000.00 |